AKAAF yields 4.64% · PFE yields 6.13%● Live data
📍 AKAAF pulled ahead of the other in Year 1
Combined, AKAAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKAAF + PFE for your $10,000?
Aker ASA operates as an industrial investment company in Norway, the European Union, North America, South America, Asia, and internationally. It operates in two segments, Industrial Holdings and Financial Investments. The company engages in the exploration and production of oil and gas; provides solutions, products, and services to the energy industry; develops and delivers technologies to drilling market; holds oil reserves; and harvests, develops, markets, and sells krill-based ingredients and product for nutraceutical, aquaculture, and animal feed applications. It also focuses on renewable energy and green technologies; builds and operates sea-based salmon farming; offers Cognite Data Fusion that collects, processes, and facilitates big data for its industry customers; designs, constructs, and leases vessels; owns and operates supply-vessels, anchor handling vessels, and construction service vessels; trades in financial instruments; operates platform for venture capital in industrial technology; develops real estate and software; acts as an investment manager; and invests in bitcoin, and projects and companies throughout the bitcoin ecosystem. The company was founded in 1841 and is based in Lysaker, Norway. Aker ASA is a subsidiary of TRG Holding AS.
Full AKAAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.